Vaccination for coronavirus disease 2019: Opportunity, hope and chalenges

Keyphrases

• COVID-19 100%
• Vaccination 100%
• COVID-19 Vaccine 100%
• Vaccine Development 66%
• Vaccine Design 33%
• Associated Diseases 33%
• Antibody-dependent Enhancement 33%
• General Public 33%
• Protein-based 33%
• Ethics 33%
• Global Threats 33%
• Clinical Trials 33%
• Previous Experience 33%
• Cellular Immunity 33%
• Humoral Immunity 33%
• Peptide-based 33%
• Misinformation 33%
• Antigen-presenting Cells 33%
• Attenuated Virus 33%
• Viral Vectors 33%
• Vector-based 33%
• Vaccine Types 33%
• Safety Self-efficacy 33%
• Viral Proteins 33%
• Inactivated Virus 33%
• Equitable Distribution 33%
• Medical Research 33%
• Upscale 33%
• Declaration of Helsinki 33%
• Vaccine Trial 33%
• Novel Vaccine Platforms 33%
• Disease Enhancement 33%
• Global Partnerships 33%
• Viral Peptides 33%

Medicine and Dentistry

• COVID-19 100%
• Hope 100%
• COVID-19 Vaccine 100%
• Clinical Trial 66%
• Vaccine Development 33%
• Weakness 33%
• Antibody Dependent Enhancement 33%
• Cellular Immunity 33%
• Medical Research 33%
• Virus Inactivation 33%
• Humoral Immunity 33%
• Virus Vector 33%
• Antigen Presenting Cell 33%
• Virus Attenuation 33%
• Messenger RNA 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronavirinae 100%
• COVID-19 Vaccine 100%
• Diseases 100%
• Clinical Trial 66%
• Vaccine Development 33%
• Antibody Dependent Enhancement 33%
• Weakness 33%
• Viral Vector 33%
• Messenger RNA 33%